Agea Medical is $2 million shy of its $8 million funding round goal
Officials at Agea Medical said it is closing in on an $8 million funding round.
The Redwood City, Calif.-based medical device company has raised $6 million for its coffers and is close to its goal.
Agea markets a system that uses vapor to ablate uterine cavity tissues. The company develops medical technology to treat excessive menstrual bleeding, a condition the company says impacts 1 in 4 women in the U.S.
In 2011, the company landed a $13.3 million private equity funding round led by medical device giant Covidien.
Company SEC filings did not disclose the investors involved in the current offering.
Teleflex expands a Class I recall for Maquet Servo 163 humidifiers and beats expectations with its...
Nikon, best known for its cameras, moves into medtech with Optos buy
A single human error in India prompts GE Healthcare to issue a warning on 30 years worth of its MRI...
Staar Surgical posts net losses for the 4th quarter and 2014 but comes close to meeting earnings...